Education
About Us
Working with TipRanks
Follow Us
Marimed (TSE:MRMD)
:MRMD
MRMD Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.06 - C$0.48
Previous CloseN/A
Volume0.00
Average Volume (3M)123.36K
Market Cap
C$72.83M
Enterprise ValueC$120.72M
Total Cash (Recent Filing)C$5.94M
Total Debt (Recent Filing)C$87.03M
Price to Earnings (P/E)―
Beta0.87
Next Earnings
Nov 05, 2025EPS Estimate
-0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding392,309,970
10 Day Avg. Volume18,017
30 Day Avg. Volume123,358
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$0.35Price Target Upside19.76% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
MariMed News
MRMD FAQ
What was Marimed’s price range in the past 12 months?
Marimed lowest stock price was C$0.06 and its highest was C$0.48 in the past 12 months.
What is Marimed’s market cap?
Marimed’s market cap is C$72.83M.
When is Marimed’s upcoming earnings report date?
Marimed’s upcoming earnings report date is Nov 05, 2025 which is in 40 days.
How were Marimed’s earnings last quarter?
Marimed released its earnings results on Aug 06, 2025. The company reported C$0 earnings per share for the quarter, beating the consensus estimate of -C$0.014 by C$0.014.
Is Marimed overvalued?
According to Wall Street analysts Marimed’s price is currently Undervalued.
Does Marimed pay dividends?
Marimed does not currently pay dividends.
What is Marimed’s EPS estimate?
Marimed’s EPS estimate is -0.01.
How many shares outstanding does Marimed have?
Marimed has 392,309,970 shares outstanding.
What happened to Marimed’s price movement after its last earnings report?
Marimed reported an EPS of C$0 in its last earnings report, beating expectations of -C$0.014. Following the earnings report the stock price went down -6.667%.
Which hedge fund is a major shareholder of Marimed?
Currently, no hedge funds are holding shares in TSE:MRMD
MariMed Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
C$0.35 (19.76% Upside)
C$0.35 (19.76% Upside)
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.3%
Last 30 Days ▼ 7.2%
Last 30 Days ▼ 7.2%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-15.69%
12-Months-Change
Fundamentals
Return on Equity
-24.41%
Trailing 12-Months
Asset Growth
-2.00%
Trailing 12-Months
Company Description
Marimed
MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company offers cannabis genetics produce flowers and concentrates under the Nature's Heritage brand; cannabis-infused products in the form of chewable tablets and powder drink mixes under the brand Kalm Fusion; natural fruit chews under the Betty's Eddies brand; brownies, cookies, and other social sweets under the Bubby's Baked brand; and cannabidiol formulations under the Florance brand. It also licenses its brands and product formulations, as well as leases cannabis facilities. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts.
MRMD Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflected a generally positive sentiment with notable growth in sequential revenue, wholesale and retail operations, and successful expansion into new markets like Delaware and Pennsylvania. However, challenges such as year-over-year revenue decline, performance issues in Missouri, and competition affecting the Metropolis dispensary were also highlighted.View all TSE:MRMD earnings summariesMRMD Stock 12 Month Forecast
Average Price Target
C$0.35
▲(19.76% Upside)
Technical Analysis
Options Prices
Currently, No data available
---